- Home
- SHFS vs SILO Comparison
SHFS vs SILO Comparison
Compare SHFS & SILO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SHFS
- SILO
- Stock Information
- Founded
- SHFS 2015
- SILO 2010
- Country
- SHFS United States
- SILO United States
- Employees
- SHFS N/A
- SILO N/A
- Industry
- SHFS Finance: Consumer Services
- SILO Apparel
- Sector
- SHFS Finance
- SILO Consumer Discretionary
- Exchange
- SHFS Nasdaq
- SILO Nasdaq
- Market Cap
- SHFS 9.5M
- SILO 8.0M
- IPO Year
- SHFS N/A
- SILO N/A
- Fundamental
- Price
- SHFS $2.74
- SILO $0.54
- Analyst Decision
- SHFS
- SILO
- Analyst Count
- SHFS 0
- SILO 0
- Target Price
- SHFS N/A
- SILO N/A
- AVG Volume (30 Days)
- SHFS 76.8K
- SILO 840.4K
- Earning Date
- SHFS 11-12-2025
- SILO 11-12-2025
- Dividend Yield
- SHFS N/A
- SILO N/A
- EPS Growth
- SHFS N/A
- SILO N/A
- EPS
- SHFS N/A
- SILO N/A
- Revenue
- SHFS $11,720,493.00
- SILO $72,102.00
- Revenue This Year
- SHFS N/A
- SILO $1.86
- Revenue Next Year
- SHFS N/A
- SILO N/A
- P/E Ratio
- SHFS N/A
- SILO N/A
- Revenue Growth
- SHFS N/A
- SILO N/A
- 52 Week Low
- SHFS $1.84
- SILO $0.40
- 52 Week High
- SHFS $10.53
- SILO $3.37
- Technical
- Relative Strength Index (RSI)
- SHFS 36.04
- SILO 38.98
- Support Level
- SHFS $2.77
- SILO $0.53
- Resistance Level
- SHFS $3.52
- SILO $0.62
- Average True Range (ATR)
- SHFS 0.40
- SILO 0.06
- MACD
- SHFS -0.19
- SILO -0.01
- Stochastic Oscillator
- SHFS 6.38
- SILO 51.62
About SHFS SHF Holdings Inc.
SHF Holdings Inc is a financial services provider to cannabis-related businesses. It offers reliable access to banking solutions for cannabis, hemp, CBD, and ancillary operators, making communities safer, driving growth in local economies, and fostering long-term partnerships. The group, through its financial institution clients, implements accountability, transparency, monitoring, reporting, and risk mitigation measures while meeting Bank Secrecy Act obligations in line with FinCEN guidance on cannabis-related businesses. Its services include Program Management Support, Customer Generation, Ongoing Program Auditing, and Compliance Monitoring, among others.
About SILO Silo Pharma Inc.
SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's primary program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders.